139 related articles for article (PubMed ID: 17670849)
1. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus.
Kasparian A; Floros A; Gialafos E; Kanakis M; Tassiopoulos S; Kafasi N; Vaiopoulos G
Lupus; 2007; 16(7):505-8. PubMed ID: 17670849
[TBL] [Abstract][Full Text] [Related]
2. Raynaud's phenomenon in systemic lupus erythematosus.
Lavras Costallat LT; Valente Coimbra AM
Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients.
Li EK; Tam LS
J Rheumatol; 1999 Sep; 26(9):1923-9. PubMed ID: 10493670
[TBL] [Abstract][Full Text] [Related]
4. Primary and secondary pulmonary hypertension in systemic lupus erythematosus.
Pan TL; Thumboo J; Boey ML
Lupus; 2000; 9(5):338-42. PubMed ID: 10878725
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.
Cefle A; Inanc M; Sayarlioglu M; Kamali S; Gul A; Ocal L; Aral O; Konice M
Rheumatol Int; 2011 Feb; 31(2):183-9. PubMed ID: 20012052
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
[TBL] [Abstract][Full Text] [Related]
7. [Systemic lupus erythematosus associated pulmonary arterial hypertension: clinical analysis of 91 cases].
Teng J; Zhang W
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):969-72. PubMed ID: 24851680
[TBL] [Abstract][Full Text] [Related]
8. Is there a difference in systemic lupus erythematosus with and without Raynaud's phenomenon?
Pavlov-Dolijanovic S; Damjanov NS; Vujasinovic Stupar NZ; Marcetic DR; Sefik-Bukilica MN; Petrovic RR
Rheumatol Int; 2013 Apr; 33(4):859-65. PubMed ID: 22618491
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
Kommireddy S; Bhyravavajhala S; Kurimeti K; Chennareddy S; Kanchinadham S; Rajendra Vara Prasad I; Rajasekhar L
Rheumatology (Oxford); 2015 Sep; 54(9):1673-9. PubMed ID: 25929760
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
Riveros Frutos A; Casas I; Rúa-Figueroa I; López-Longo FJ; Calvo-Alén J; Galindo M; Fernández-Nebro A; Pego-Reigosa JM; Olivé Marqués A;
Lupus; 2017 Jun; 26(7):698-706. PubMed ID: 27799439
[TBL] [Abstract][Full Text] [Related]
11. Raynaud's phenomenon and pulmonary arterial hypertension.
Callejas-Rubio JL; López-Pérez L; Moreno-Escobar E; Ortego-Centeno N
Lupus; 2008 Apr; 17(4):355. PubMed ID: 18413419
[No Abstract] [Full Text] [Related]
12. Usefulness of the pulmonary arterial systolic pressure to predict pulmonary arterial wedge pressure in patients with normal left ventricular systolic function.
Bouchard JL; Aurigemma GP; Hill JC; Ennis CA; Tighe DA
Am J Cardiol; 2008 Jun; 101(11):1673-6. PubMed ID: 18489950
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
14. Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study.
Castillo-Martínez D; Marroquín-Fabián E; Lozada-Navarro AC; Mora-Ramírez M; Juárez M; Sánchez-Muñoz F; Vargas-Barrón J; Sandoval J; Amezcua-Guerra LM
Lupus; 2016 Jan; 25(1):61-6. PubMed ID: 26306740
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the nailfold capillary morphology associated with Raynaud phenomenon in patients with systemic lupus erythematosus.
Caspary L; Schmees C; Schoetensack I; Hartung K; Stannat S; Deicher H; Creutzig A; Alexander K
J Rheumatol; 1991 Apr; 18(4):559-66. PubMed ID: 2066948
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in systemic lupus erythematosus.
Simonson JS; Schiller NB; Petri M; Hellmann DB
J Rheumatol; 1989 Jul; 16(7):918-25. PubMed ID: 2769664
[TBL] [Abstract][Full Text] [Related]
17. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
18. An autopsied case of systemic lupus erythematosus with pulmonary hypertension--a case report.
KanemotO N; Sato M; Moriuchi J; Ichikawa Y; Goto Y; Sasadaira H
Angiology; 1988 Feb; 39(2):187-92. PubMed ID: 3348494
[TBL] [Abstract][Full Text] [Related]
19. Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus.
Buyukhatipoglu H; Buyukaslan H; Pehlivan Y; Ceylan N; Ulas T; Tarakcioglu M; Onat AM
Int J Rheum Dis; 2011 Aug; 14(3):276-81. PubMed ID: 21816024
[TBL] [Abstract][Full Text] [Related]
20. Alopecia in systemic lupus erythematosus. Relation to disease manifestations.
Wysenbeek AJ; Leibovici L; Amit M; Weinberger A
J Rheumatol; 1991 Aug; 18(8):1185-6. PubMed ID: 1941821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
